Biotech Holdings is a pharmaceutical production and distribution company based in Vancouver, Canada.

Biotech has developed an important new anti-diabetic medication, which has been trademarked as "Sucanon" and "Diab II". Biotech is now focused on the distribution and marketing of this medication. The Company also looks forward to development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world's most widespread and rapidly growing diseases.

Contact Information

3751Shell Road
Suite 160
Richmond, BC V6X2W2

fax: 1604-295-1110


Investor Relations

e-mail: biotech@direct.ca


Exchange: TSX-V
Industry: Unknown
Market Cap: N/A

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.